Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amneal Pharmaceuticals Inc
(NY:
AMRX
)
N/A
UNCHANGED
Last Price
Updated: 7:00 PM EST, Dec 26, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
5.710 (1)
Ask (Size)
6.000 (1)
Prev. Close
5.870
Today's Range
N/A - N/A
52wk Range
3.360 - 5.800
Shares Outstanding
1,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California
May 22, 2024
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal to Participate at Upcoming Investor Conference
May 22, 2024
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Performance
More News
Read More
Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade
May 16, 2024
Via
InvestorPlace
Topics
Intellectual Property
Exposures
Intellectual Property
Assessing Amneal Pharmaceuticals: Insights From 4 Financial Analysts
May 06, 2024
Via
Benzinga
Generic Drugmaker Amneal Announces Over $270M In US Opioid Lawsuit Settlement
May 03, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Amneal Pharmaceuticals: Q4 Earnings Insights
March 01, 2024
Via
Benzinga
Earnings Outlook For Amneal Pharmaceuticals
February 29, 2024
Via
Benzinga
AMRX Stock Earnings: Amneal Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024
May 03, 2024
Via
InvestorPlace
Amneal Reports First Quarter 2024 Financial Results
May 03, 2024
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
April 24, 2024
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine
April 16, 2024
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal to Report First Quarter 2024 Results on May 3, 2024
April 10, 2024
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal to Ring the Nasdaq Closing Bell on April 2, 2024
March 28, 2024
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension
March 25, 2024
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Why Is Generic Drug-Focused Amneal Pharmaceuticals Stock Trading Lower Friday?
March 01, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
March 01, 2024
Via
InvestorPlace
Earnings Scheduled For March 1, 2024
March 01, 2024
Via
Benzinga
Amneal Reports Fourth Quarter and Full Year 2023 Financial Results
March 01, 2024
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal Enters into Exclusive European Licensing Agreement with Zambon Biotech for IPX203
February 27, 2024
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
6 reasons to buy Teva Pharmaceuticals stock sooner than later
February 26, 2024
Via
MarketBeat
Topics
Lawsuit
Exposures
Financial
Legal
Amneal to Participate at Upcoming Investor Conference
February 13, 2024
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal to Report Fourth Quarter and Full Year 2023 Results on March 1, 2024
January 31, 2024
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal Launches Complex Generic Fluorometholone Ophthalmic Suspension
January 10, 2024
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal Launched Record Number of 39 New Retail and Injectable Products in 2023, Including 13 in Q4 2023
January 04, 2024
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Amneal to Participate at the 42nd Annual J.P. Morgan Healthcare Conference
December 21, 2023
From
Amneal Pharmaceuticals, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.